Genenta Science S.p.A. (GNTA)
NASDAQ: GNTA · Real-Time Price · USD
3.690
-0.189 (-4.87%)
Apr 17, 2025, 4:00 PM EDT - Market closed

Genenta Science Income Statement

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Selling, General & Admin
4.955.265.712.30.9
Upgrade
Research & Development
4.816.475.343.394.69
Upgrade
Operating Expenses
9.7611.7311.045.695.59
Upgrade
Operating Income
-9.76-11.73-11.04-5.69-5.59
Upgrade
Interest Expense
----0.01-0.01
Upgrade
Interest & Investment Income
0.080.310.04--
Upgrade
Currency Exchange Gain (Loss)
0.24-0.222.29--
Upgrade
Other Non Operating Income (Expenses)
0.53-00.240.020.01
Upgrade
EBT Excluding Unusual Items
-8.91-11.65-8.48-5.68-5.59
Upgrade
Other Unusual Items
---0.15-
Upgrade
Pretax Income
-8.91-11.65-8.48-5.53-5.59
Upgrade
Net Income
-8.91-11.65-8.48-5.53-5.59
Upgrade
Net Income to Common
-8.91-11.65-8.48-5.53-5.59
Upgrade
Shares Outstanding (Basic)
1818181515
Upgrade
Shares Outstanding (Diluted)
1818181515
Upgrade
Shares Change (YoY)
0.31%-20.77%3.74%14.93%
Upgrade
EPS (Basic)
-0.49-0.64-0.47-0.37-0.38
Upgrade
EPS (Diluted)
-0.49-0.64-0.47-0.37-0.38
Upgrade
Free Cash Flow
-6.24-11.22-7.45-6.97-6.07
Upgrade
Free Cash Flow Per Share
-0.34-0.62-0.41-0.46-0.42
Upgrade
EBITDA
-9.72-11.69-11.04-5.68-5.59
Upgrade
D&A For EBITDA
0.040.040.0100
Upgrade
EBIT
-9.76-11.73-11.04-5.69-5.59
Upgrade
Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q